Avoiding in hospital delays and eliminating the three-hour effect in thrombolysis for stroke

International Journal of Stroke

Volumn 6, Issue 6, 2011, Pages 493-497

  Köhrmann, Martin ^a   Schellinger, Peter D ^a   Breuer, Lorenz ^a   Dohrn, Maike ^a   Kuramatsu, Joji B ^a   Blinzler, Christian ^a   Schwab, Stefan ^a   Huttner, Hagen B ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Acute stroke therapy; Door to needle time; RtPA; Stroke teams; Thrombolysis

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CLINICAL PROTOCOL; CORRELATION ANALYSIS; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; STANDARDIZATION; STROKE; TIME MANAGEMENT;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; EMERGENCY MEDICAL SERVICES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT SELECTION; STROKE; SURVIVAL RATE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 82255183798     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2011.00585.x     Document Type: Article

References (17)

1. Saver JL. Time is brain-quantified. Stroke 2006; 37:263-6.
2. Lees KR, Bluhmki E, von Kummer R et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375:1695-703.
3. Hacke W, Kaste M, Bluhmki E et al. Thrombolysis with alteplase 3 to 4·5 hours after acute ischemic stroke. N Engl J Med 2008; 359:1317-29.
4. Alberts MJ, Perry A, Dawson DV, Bertels C. Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke 1992; 23:352-6.
5. Marler J, Jones P, Emr M. Rapid Identification and Treatment of Acute Stroke: Proceeding of a National Symposium. Bethesda, MD: National Institutes of Health, 1997.
6. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000; 283:1145-50.
7. Sattin JA, Olson SE, Liu L, Raman R, Lyden PD. An expedited code stroke protocol is feasible and safe. Stroke 2006; 37:2935-9.
8. Izenberg A, Silver F, Hill M et al. Earlier hospital arrival in acute stroke is associated with delayed tPA administration. Abstract, AAN 2009, Seattle, 2009:S04.006.
9. Saver JL, Smith EE, Fonarow GC et al. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in >30, 000 patients arriving within 60 minutes of stroke onset. Stroke 2010; 41:1431-9.
10. Kohrmann M, Nowe T, Huttner HB et al. Safety and outcome after thrombolysis in stroke patients with mild symptoms. Cerebrovasc Dis 2009; 27:160-6.
11. Wahlgren N, Ahmed N, Davalos A et al. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study. Lancet 2007; 369:275-82.
12. Lindsberg PJ, Happola O, Kallela M, Valanne L, Kuisma M, Kaste M. Door to thrombolysis: ER reorganization and reduced delays to acute stroke treatment. Neurology 2006; 67:334-6.
13. Ford AL, Connor LT, Tan DK, Williams JA, Lee JM, Nassief AM. Resident-based acute stroke protocol is expeditious and safe. Stroke 2009; 40:1512-4.
14. Rizos T, Herweh C, Jenetzky E et al. Point-of-care international normalized ratio testing accelerates thrombolysis in patients with acute ischemic stroke using oral anticoagulants. Stroke 2009; 40:3547-51.
15. Saposnik G, Baibergenova A, Bayer N, Hachinski V. Weekends: a dangerous time for having a stroke? Stroke 2007; 38:1211-5.
16. Jauss M, Oertel W, Allendoerfer J, Misselwitz B, Hamer H. Bias in request for medical care and impact on outcome during office and non-office hours in stroke patients. Eur J Neurol 2009; 16:1165-7.
17. Wahlgren N, Ahmed N, Eriksson N et al. Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST). Stroke 2008; 39:3316-22.